Synthesis, Type II Diabetes Inhibitory Activity, and Antimicrobial Tests of Benzothiazole Derivatives Bridged with Indenedione by Methylenehydrazone

S. Mor; S. Sindhu; M. Khatri; N. Singh; N. Vasudeva; N. Panihar

doi:10.1134/S1070363219090226

Synthesis, Type II Diabetes Inhibitory Activity, and Antimicrobial Tests of Benzothiazole Derivatives Bridged with Indenedione by Methylenehydrazone

Authors: Mor S.¹, Sindhu S.¹, Khatri M.¹, Singh N.², Vasudeva N.³, Panihar N.³
Affiliations:
1. Department of Chemistry
2. Department of Bio and Nanotechnology
3. Department of Pharmaceutical Sciences
Issue: Vol 89, No 9 (2019)
Pages: 1867-1873
Section: Article
URL: https://journals.rcsi.science/1070-3632/article/view/223085
DOI: https://doi.org/10.1134/S1070363219090226
ID: 223085

Cite item

Full Text

Open Access
Restricted Access

Access granted
Restricted Access

Subscription Access

Abstract
About the authors
References
Statistics

Abstract

Benzothiazolyl hydrazones are synthesized and tested as hypoglycemic and antimicrobial agents. Condensation of 2-acyl-(1H)-indene-1,3(2H)-diones with 2-hydrazinylbenzo[d]thiazole/2-hydrazinyl-6-substitutedbenzo[d]thiazoles gives the corresponding hydrazones in high yields. Preliminary biological assay of the products reveals significant antidiabetic and antimicrobial activities. The α-amylase and α-glucosidase inhibition assay is used for determination of Type II diabetes inhibitory activity.